These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29689561)

  • 21. Management of hyperuricemia in asymptomatic patients: A critical appraisal.
    Brucato A; Cianci F; Carnovale C
    Eur J Intern Med; 2020 Apr; 74():8-17. PubMed ID: 31952982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
    Torres RJ; Puig JG
    Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Drug Treatments for Lowering Uric Acid on Renal Function in Patients With Chronic Kidney Disease and Hyperuricemia: A Network Meta-Analysis of Randomized Controlled Trials.
    Liu X; Qiu Y; Li D; Tan J; Liang X; Qin W
    Front Pharmacol; 2021; 12():690557. PubMed ID: 34413775
    [No Abstract]   [Full Text] [Related]  

  • 24. [URATE AS A POTENTIAL RISK FACTOR OF CARDIOVASCULAR AND RENAL DISEASES].
    Butković M
    Acta Med Croatica; 2016 Dec; 70(4-5):233-9. PubMed ID: 29087102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemia.
    Xu S; Liu X; Ming J; Chen S; Wang Y; Liu X; Liu H; Peng Y; Wang J; Lin J; Ji H; Liu B; Lu Y; Liu P; Zhang Y; Ji Q
    Int J Rheum Dis; 2015 Jul; 18(6):669-78. PubMed ID: 26013187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients.
    Ohno I; Yamaguchi Y; Saikawa H; Uetake D; Hikita M; Okabe H; Ichida K; Hosoya T
    Intern Med; 2009; 48(6):415-20. PubMed ID: 19293539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
    Bove M; Cicero AF; Veronesi M; Borghi C
    Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How should we manage asymptomatic hyperuricemia?
    Chalès G
    Joint Bone Spine; 2019 Jul; 86(4):437-443. PubMed ID: 30316974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperuricemia, the heart, and the kidneys - to treat or not to treat?
    Petreski T; Ekart R; Hojs R; Bevc S
    Ren Fail; 2020 Nov; 42(1):978-986. PubMed ID: 32972284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia.
    Shahinfar S; Simpson RL; Carides AD; Thiyagarajan B; Nakagawa Y; Umans JG; Parks JH; Coe FL
    Kidney Int; 1999 Nov; 56(5):1879-85. PubMed ID: 10571797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal arthropathies: recognizing and treating "the gouch".
    Quillen DM
    Prim Care; 2010 Dec; 37(4):703-11, v. PubMed ID: 21050952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylaxis for acute gout flares after initiation of urate-lowering therapy.
    Latourte A; Bardin T; Richette P
    Rheumatology (Oxford); 2014 Nov; 53(11):1920-6. PubMed ID: 24758886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis.
    Zhang L; An K; Mou X; Zhang M; Su Q; Li S
    Front Pharmacol; 2021; 12():795082. PubMed ID: 35115941
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors influencing Urate Lowering Therapies prescription for asymptomatic hyperuricemia by general practitioners: a qualitative study.
    Tourzel E; Munck S; Fournier JP; Maisonneuve H
    Int J Clin Pract; 2019 Sep; 73(9):1-11. PubMed ID: 31250954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and (pharmaco)kinetics of one single dose of rasburicase in patients with chronic kidney disease.
    Sestigiani E; Mandreoli M; Guardigli M; Roda A; Ramazzotti E; Boni P; Santoro A
    Nephron Clin Pract; 2008; 108(4):c265-71. PubMed ID: 18418005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.